Published in Neurology on July 27, 2010
Aquaporin 4 and neuromyelitis optica. Lancet Neurol (2012) 2.58
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol (2014) 1.53
Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol (2014) 1.38
Demographic and clinical features of neuromyelitis optica: A review. Mult Scler (2015) 1.14
Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int (2012) 1.10
New insights into neuromyelitis optica. J Clin Neurol (2011) 1.09
Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol (2012) 1.09
Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int J Biochem Cell Biol (2012) 1.04
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Int J Mol Sci (2016) 0.93
Molecular pathogenesis of neuromyelitis optica. Int J Mol Sci (2012) 0.92
Optic neuritis in neuromyelitis optica. Prog Retin Eye Res (2013) 0.90
Orthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms. J Neuroimmunol (2011) 0.87
Anti-aquaporin-4 antibody-positive familial neuromyelitis optica in mother and daughter. Jpn J Ophthalmol (2011) 0.78
Protective environmental factors for neuromyelitis optica. Neurology (2014) 0.75
The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population. Medicine (Baltimore) (2015) 0.75
Variants of Interferon Regulatory Factor 5 are Associated with Neither Neuromyelitis Optica Nor Multiple Sclerosis in the Southeastern Han Chinese Population. Chin Med J (Engl) (2015) 0.75
STAT4 Polymorphisms are Associated with Neuromyelitis Optica Spectrum Disorders. Neuromolecular Med (2017) 0.75
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population. Jpn J Ophthalmol (2016) 0.75
Association of TNFSF4 Polymorphisms with Neuromyelitis Optica Spectrum Disorders in a Chinese Population. J Mol Neurosci (2017) 0.75
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
The spectrum of neuromyelitis optica. Lancet Neurol (2007) 11.83
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol (2009) 3.91
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology (2007) 3.83
NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology (2008) 3.21
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol (2008) 1.59
An epidemiological study of neuromyelitis optica in Cuba. J Neurol (2009) 1.30
Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport (2009) 1.19
Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler (2009) 1.15
The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun (2009) 1.12
NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler (2008) 1.12
Neuromyelitis optica. Curr Opin Neurol (2007) 1.10
Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens (2009) 1.04
Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol Dis (2009) 1.02
Environmental changes and epidemiology of multiple sclerosis in the French West Indies. J Neurol Sci (2009) 0.94
Neuromyelitis optica in a mother and daughter. Arch Neurol (2007) 0.94
Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan. Neurology (2000) 0.89
Polymorphisms in the neuromyelitis optica auto-antigen AQP4 and susceptibility to multiple sclerosis. J Neurol (2007) 0.85
Neuromyelitis optica (Devic's syndrome) in two sisters. Clin Electroencephalogr (1982) 0.82
Neuromyelitis optica and multiple sclerosis in sisters. Mult Scler (2008) 0.81
Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (1997) 0.79
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
Multiple sclerosis. N Engl J Med (2000) 12.69
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology (2008) 5.31
Control of circadian rhythms and photoperiodic flowering by the Arabidopsis GIGANTEA gene. Science (1999) 4.42
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med (1998) 4.34
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem (2000) 3.45
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology (2009) 3.43
Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology (2011) 3.30
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Tn10 transposase acts preferentially on nearby transposon ends in vivo. Cell (1983) 3.23
NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology (2008) 3.21
A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol (2000) 3.12
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry (2001) 3.05
Optokinetic therapy improves text reading in patients with hemianopic alexia: a controlled trial. Neurology (2007) 2.91
Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med (1996) 2.91
Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J (2008) 2.84
Chronic relapsing inflammatory optic neuropathy (CRION). Brain (2003) 2.83
Treatment of primary osteoarthritis of the hip. A comparison of total joint and surface replacement arthroplasty. J Bone Joint Surg Am (1984) 2.77
Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology (1988) 2.66
Mitochondrial protein phylogeny joins myriapods with chelicerates. Nature (2001) 2.64
Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41
Management of acute optic neuritis. Lancet (2002) 2.33
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32
Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB. Eur Respir J (2009) 2.15
A prospective randomised comparison of two insertion methods for i-gel placement in anaesthetised paralysed patients: standard vs. rotational technique. Anaesthesia (2014) 2.11
CNS aquaporin-4 autoimmunity in children. Neurology (2008) 2.10
Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J (2001) 2.03
Comparison of techniques for double-lumen endobronchial intubation: 90° or 180° rotation during advancement through the glottis. Br J Anaesth (2013) 2.03
Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil (2012) 2.03
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis. Ann Oncol (2013) 2.02
Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol (2011) 2.00
Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J Cell Biol (2001) 1.99
Economic burden of smoking in Korea. Tob Control (2003) 1.99
Reproducibility of random amplified polymorphic DNA (RAPD) analysis among laboratories. PCR Methods Appl (1993) 1.97
Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88
Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract (1999) 1.87
The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids (2006) 1.86
Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab. Neurology (2011) 1.85
Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy (1998) 1.85
Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy (2012) 1.81
Epilepsy surgery, visual fields, and driving: a study of the visual field criteria for driving in patients after temporal lobe epilepsy surgery with a comparison of Goldmann and Esterman perimetry. J Neurol Neurosurg Psychiatry (2000) 1.77
A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology (2007) 1.70
The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci (2001) 1.70
Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int (2009) 1.70
Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids (2006) 1.69
A new strategy to predict the neoplastic polyps of the gallbladder based on a scoring system using EUS. Gastrointest Endosc (2000) 1.69
Multicentre study of the safety of laparoscopic subtotal gastrectomy for gastric cancer in the elderly. Br J Surg (2009) 1.69
The functional anatomy of single-word reading in patients with hemianopic and pure alexia. Brain (2001) 1.66
Thin aggregative fimbriae and cellulose enhance long-term survival and persistence of Salmonella. J Bacteriol (2006) 1.65
Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology (2011) 1.64
Mechanisms of fenretinide-induced apoptosis. Apoptosis (2006) 1.64
Beyond prejudice as simple antipathy: hostile and benevolent sexism across cultures. J Pers Soc Psychol (2000) 1.62
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J (2006) 1.61
Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye (Lond) (2013) 1.61
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry (2005) 1.59
Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (2009) 1.58
Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology (1997) 1.58
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med (2001) 1.56
Optic neuritis: a review. Int MS J (2009) 1.55
A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet (2000) 1.54
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem (1999) 1.54
IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ (2009) 1.53
A 'web app' for diagnosing hemianopia. J Neurol Neurosurg Psychiatry (2012) 1.53
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"? J Gastrointest Surg (2013) 1.52
Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology (2004) 1.51
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer. Br J Cancer (2013) 1.50
Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology (2001) 1.50
Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control (2004) 1.47
Fresh osteochondral allografts for posttraumatic knee defects: long-term followup. Clin Orthop Relat Res (2008) 1.47
Primary stenting for acute myocardial infarction via the transradial approach: a safe and useful alternative to the transfemoral approach. J Invasive Cardiol (2000) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes (2000) 1.46
Oleoyl-CoA is the major de novo product of stearoyl-CoA desaturase 1 gene isoform and substrate for the biosynthesis of the Harderian gland 1-alkyl-2,3-diacylglycerol. J Biol Chem (2001) 1.45
Anticardiolipin and antineutrophil antibodies in giant cell arteritis. J Rheumatol (1990) 1.45
A window of opportunity for no treatment in early multiple sclerosis? Mult Scler (2010) 1.45
Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem (1996) 1.45
Intracardiac thrombus formation induced by carbon monoxide poisoning. Hum Exp Toxicol (2013) 1.45
The Department of Neurosurgery at Seoul National University: past, present, and future. Neurosurgery (2001) 1.44
Complete ophthalmoplegia as a complication of acute corticosteroid- and pancuronium-associated myopathy. Neurology (1991) 1.44
Cellular motor protein KIF-4 associates with retroviral Gag. J Virol (1999) 1.43
Copper-binding compounds from Methylosinus trichosporium OB3b. J Bacteriol (1998) 1.43
Change of insulin sensitivity in hepatitis C patients with normal insulin sensitivity: a 5-year prospective follow-up study variation of insulin sensitivity in HCV patients. Intern Med J (2009) 1.43
Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood. Exp Hematol (1997) 1.43
Chronic hypertension and left ventricular hypertrophy facilitate induction of sustained ventricular tachycardia in dogs 3 hours after left circumflex coronary artery occlusion. J Am Coll Cardiol (1989) 1.43
Risk factors for recurrence of primary bile duct stones after endoscopic biliary sphincterotomy. Gastrointest Endosc (2001) 1.42
HTLV-1 associated myelopathy in Canada. Can J Neurol Sci (1989) 1.40
[Treatment of optic neuritis]. Ned Tijdschr Geneeskd (2004) 1.39
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology (2006) 1.39
Pseudobasophilia as an erroneous white blood cell differential count with a discrepancy between automated cell counters: report of two cases. Clin Lab Haematol (2004) 1.39
Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett (2008) 1.39
Kinetic roughening of ion-sputtered Pd(001) surface: beyond the Kuramoto-Sivashinsky model. Phys Rev Lett (2004) 1.38
Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37
Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem (1998) 1.37